These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8674066)

  • 1. Loss of DNA mismatch repair in acquired resistance to cisplatin.
    Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
    Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
    Aebi S; Fink D; Gordon R; Kim HK; Zheng H; Fink JL; Howell SB
    Clin Cancer Res; 1997 Oct; 3(10):1763-7. PubMed ID: 9815561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.
    Brown R; Hirst GL; Gallagher WM; McIlwrath AJ; Margison GP; van der Zee AG; Anthoney DA
    Oncogene; 1997 Jul; 15(1):45-52. PubMed ID: 9233776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by overexpression of hMSH2 or hMLH1.
    Zhang H; Richards B; Wilson T; Lloyd M; Cranston A; Thorburn A; Fishel R; Meuth M
    Cancer Res; 1999 Jul; 59(13):3021-7. PubMed ID: 10397236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.
    Glaab WE; Tindall KR
    Carcinogenesis; 1997 Jan; 18(1):1-8. PubMed ID: 9054582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.
    Branch P; Masson M; Aquilina G; Bignami M; Karran P
    Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
    Shin KH; Park JG
    Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
    Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
    Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
    Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA
    Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.
    Lee DF; Drouin R; Pitsikas P; Rainbow AJ
    Cancer Res; 2004 Jun; 64(11):3865-70. PubMed ID: 15172995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin.
    Fink D; Nebel S; Norris PS; Baergen RN; Wilczynski SP; Costa MJ; Haas M; Cannistra SA; Howell SB
    Int J Cancer; 1998 Aug; 77(5):741-6. PubMed ID: 9688308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
    Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
    J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
    Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
    Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.
    Colella G; Marchini S; D'Incalci M; Brown R; Broggini M
    Br J Cancer; 1999 May; 80(3-4):338-43. PubMed ID: 10408835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
    Leadon SA; Avrutskaya AV
    Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
    Ma AH; Xia L; Littman SJ; Swinler S; Lader G; Polinkovsky A; Olechnowicz J; Kasturi L; Lutterbaugh J; Modrich P; Veigl ML; Markowitz SD; Sedwick WD
    Oncogene; 2000 Apr; 19(18):2249-56. PubMed ID: 10822375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
    Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
    Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.